Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

6.39
Delayed Data
As of Jul 31
 +0.30 / +4.93%
Today’s Change
3.05
Today|||52-Week Range
8.61
-20.22%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 9.00. The median estimate represents a +119.09% increase from the last price of 6.39.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$10.6M
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.94%
 
 
 
 
 
 
Growthannually -178.54%
 
 
 
 
 
 

Sales

Growthquarterly 62.53%
 
 
 
 
 
 
Growthannually -23.93%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.